Jacob Asset Management Of New York LLC Athersys, Inc Transaction History

Jacob Asset Management Of New York LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.18 - $0.86 $36,000 - $172,000	-200,000 Reduced 30.77%	450,000 $117,000
Q1 2022 May 12, 2022	SELL	$0.6 - $1.06 $102,000 - $180,200	-170,000 Reduced 20.73%	650,000 $394,000
Q3 2021 Nov 12, 2021	BUY	$1.33 - $1.77 $133,000 - $177,000	100,000 Added 13.89%	820,000 $1.09 Million
Q2 2021 Oct 04, 2021	BUY	$1.41 - $1.94 $197,400 - $271,600	140,000 Added 24.14%	720,000 $1.04 Million
Q1 2021 Oct 04, 2021	BUY	$1.61 - $2.77 $563,500 - $969,500	350,000 Added 152.17%	580,000 $1.04 Million
Q4 2020 Oct 04, 2021	BUY	$1.55 - $2.24 $356,500 - $515,200	230,000 New	230,000 $403,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Jacob Asset Management Of New York LLC, based on Form 13F filings with the SEC.

Stay updated on Jacob Asset Management Of New York LLC with notifications on news.